Michael S. Cuffe, EVP and Chief Clinical Officer at HCA Healthcare, Inc. (HCA), sold 18,449 shares at $309.00 ($4.4M) on 2024-05-06, disclosed to the SEC on 2024-05-08.
Seasonal sale ($4.4M) by EVP and Chief Clinical Officer — this insider has traded HCA in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $309.00 | 1,600 | $494K | 11.3% |
| 2 | $314.45 | 12,349 | $3.9M | 88.7% |
| 3 | $0.00 | 4,500 | $0 | 0.0% |
| Total | $237.28 avg | 18,449 | $4.4M | 100% |
| Filing → |
| HCA | SELL | 2024-09-12 | $6.4M | — | Filing → |
| HCA | SELL | 2024-05-13 | $4.0M | — | Filing → |
| HCA | SELL | 2024-02-02 | $2.0M | — | Filing → |